Literature DB >> 32072324

Intratumoral pseudoaneurysm within a liver metastasis of gastric cancer: a case report.

Hiroki Ohara1, Yuji Ishibashi2, Shuntaro Yoshimura1, Ryoto Yamazaki3, Fumihiko Hatao1, Takeshi Koshiishi4, Yasuhiro Morita1, Kazuhiro Imamura1.   

Abstract

BACKGROUND: Intrahepatic artery pseudoaneurysms are mostly iatrogenic and result from hepatobiliary interventions. The incidence of intrahepatic artery pseudoaneurysms within liver tumors without prior intervention is extremely rare. We presented herein the first report of a case of an intratumoral pseudoaneurysm within a liver metastasis of gastric cancer without any prior intervention during chemotherapy. CASE
PRESENTATION: A 59-year-old male patient underwent a distal gastrectomy and D2 lymph node dissection for gastric cancer. He was treated in the emergency room for right abdominal pain following the 4th cycle of nivolumab administration as second-line chemotherapy after adjuvant chemotherapy with S-1 and first-line chemotherapy for a liver metastasis of gastric cancer with ramucirumab plus paclitaxel. CT showed a 72-mm metastatic liver tumor containing a 9-mm pseudoaneurysm and fluid collection around the hepatic edge. Intrahepatic artery pseudoaneurysm within the metastatic liver tumor was diagnosed, with the surrounding fluid indicating potential, active bleeding. An emergency angiography confirmed the presence of a pseudoaneurysm in the intrahepatic artery, which was embolized using microcoils. The contributory causes of the intratumoral pseudoaneurysm were assumed to be the following: (1) tumor necrosis leading to encasement, erosion of the vessel wall, and subsequent arterial wall weakening; and (2) inhibition of vascular endothelial growth by ramucirumab resulting in a vessel wall breach and pseudoaneurysm formation.
CONCLUSION: It is necessary to recognize that pseudoaneurysms can arise within a metastatic liver tumor during chemotherapy.

Entities:  

Keywords:  Gastric cancer; Hepatic artery; Metastatic liver tumor; Pseudoaneurysm

Year:  2020        PMID: 32072324     DOI: 10.1186/s40792-020-00806-z

Source DB:  PubMed          Journal:  Surg Case Rep        ISSN: 2198-7793


  2 in total

1.  CBX2 depletion inhibits the proliferation, invasion and migration of gastric cancer cells by inactivating the YAP/β-catenin pathway.

Authors:  Miaomiao Zeng; Bangxue Li; Lei Yang; Quanlin Guan
Journal:  Mol Med Rep       Date:  2020-12-14       Impact factor: 2.952

Review 2.  Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis.

Authors:  Suwen Bai; Zunyun Wang; Minghua Wang; Junai Li; Yuan Wei; Ruihuan Xu; Juan Du
Journal:  Front Cell Dev Biol       Date:  2022-03-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.